End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
31.33 CNY | -6.20% | -9.11% | +5.99% |
04-26 | Rianlon Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-17 | Rianlon Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Strengths
- Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last few months, analysts have been revising downwards their earnings forecast.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+5.99% | 1.06B | - | ||
+6.11% | 105B | A- | ||
-4.67% | 63.83B | A- | ||
+73.81% | 45.28B | B | ||
+15.46% | 38.93B | B | ||
+5.46% | 33.06B | A- | ||
+11.59% | 20.21B | B- | ||
+13.74% | 16.94B | C+ | ||
+20.05% | 16.08B | B- | ||
+5.02% | 14.49B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 300596 Stock
- Ratings Rianlon Corporation